ZCZC
BFF-03
VIRUS-US-REMDESIVIR-APPROVAL
US approves Gilead’s remdesivir drug for coronavirus patients: Trump
WASHINGTON, May 2, 2020 (BSS/AFP) – Gilead’s antiviral drug remdesivir has been authorized by US regulators for emergency use on coronavirus patients, President Donald Trump announced Friday.
US medical officials have announced evidence from a trial that remdesivir helped patients with serious cases of COVID-19 recover faster.
Trump has been a vocal supporter of remdesivir as a possible way to bring the novel coronavirus pandemic under control. Nearly 65,000 Americans have died in the global crisis.
BSS/AFP/MMA/0910HRS